VenoStent Completes $20 Million Series A with $4 Million Investment from Norwest Venture Partners
VenoStent builds on Momentum with New $3.6 Million NIH SBIR [...]
VenoStent builds on Momentum with New $3.6 Million NIH SBIR [...]
“We appreciate the strong support from our shareholders, and from [...]
The Series A investment marks a pivotal moment in the [...]
The funding, made up of a £790k flexible, agile, scalable, [...]
The funding will accelerate candidate selection for preclinical studies and [...]
Funding will accelerate the commercialization and adoption of the MyPhenome [...]
“Obtaining an accurate ultrasound diagnosis in time can literally be [...]
Co-led by return investor Sonder Capital and new investor NYBC [...]
PhotoniCare, in January of this year, announced that the U.S. [...]
Mitsuo Sawai, CEO of Sawai Group Holdings, highlighted their commitment [...]